£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

US Liver Cirrhosis Drug Market Outlook 2023-2028 Report

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 19 days · 19 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 12 August 2026 16 August 2026 21 August 2026 25 August 2026 30 August 2026
View at Amazon ↗

Price data last checked 72 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 19 days • 1 price levels

Days at Price
19 days 0 5 10 14 19 £490 Days at Price

Price Analysis

Most common price: £490 (19 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 19 days

Description

Gain detailed market intelligence with this study on the latent demand for liver cirrhosis drugs across the United States. This report provides potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for 10,833 individual zip codes. By analyzing these specific locations, users can identify significant market opportunities and untapped demand within the pharmaceutical landscape. The data includes comparative benchmarks, reporting the percent share each zip code holds relative to its state and the entire United States. These metrics allow for quick assessment of specific geographic areas compared to others. This statistical approach provides a foundation for developing effective distribution models and optimizing sales force strategies for the 2023-2028 period.

Key Features

Provides latent demand estimates for liver cirrhosis drugs across 10,833 US zip codes.

Includes potential industry earnings (P.I.E.) measured in millions of U.S. dollars.

Offers comparative benchmarks by reporting the percent share of each zip code relative to its state and the US.

Supports the development of targeted distribution and sales force strategies through granular geographic data.

Covers a comprehensive market outlook spanning the years 2023 through 2028.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Liver Cirrhosis Drugs in China
99% match

The 2023-2028 Outlook for Liver Cirrhosis Drugs in China

£495.00 09 Nov 2026
India Liver Cirrhosis Drugs Market Outlook 2023-2028 Study
98% match

India Liver Cirrhosis Drugs Market Outlook 2023-2028 Study

£515.00 05 Nov 2026
The 2025-2030 World Outlook for Liver Cirrhosis Drugs
98% match

The 2025-2030 World Outlook for Liver Cirrhosis Drugs

Price unavailable
The 2023-2028 Outlook for Liver Health Supplements for US Zip Codes
98% match

The 2023-2028 Outlook for Liver Health Supplements for US Zip Codes

£490.00 31 Aug 2026
The 2021-2026 World Outlook for Liver Disease Treatments
97% match

The 2021-2026 World Outlook for Liver Disease Treatments

£795.00 31 Oct 2026
Anti-Rejection Drugs and Immunosuppressants Liver Study
97% match

Anti-Rejection Drugs and Immunosuppressants Liver Study

£490.00 30 Aug 2026
World Outlook for Liver Disease Treatments 2025-2030
97% match

World Outlook for Liver Disease Treatments 2025-2030

Price unavailable
The 2023-2028 Outlook for Liver Health Supplements in China
97% match

The 2023-2028 Outlook for Liver Health Supplements in China

£495.00 27 Aug 2026
The 2023-2028 Outlook for Liver Health Supplements in Japan
97% match

The 2023-2028 Outlook for Liver Health Supplements in Japan

£495.00 03 Sep 2026
The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in Japan
97% match

The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in Japan

£495.00 19 Sep 2026
US Anti-Rejection Drugs & Immunosuppressants Liver Study
97% match

US Anti-Rejection Drugs & Immunosuppressants Liver Study

£520.00 06 Nov 2026
The 2023-2028 Outlook for Liver Health Supplements in India
97% match

The 2023-2028 Outlook for Liver Health Supplements in India

£515.00 03 Sep 2026
Liver Cirrhosis: Debates and Current Challenges
96% match

Liver Cirrhosis: Debates and Current Challenges

IntechOpen

£119.00 19 Sep 2026
World Outlook: Anti-Rejection Drugs for Liver Diseases
96% match

World Outlook: Anti-Rejection Drugs for Liver Diseases

Price unavailable
Liver Cirrhosis - Update and Current Challenges
96% match

Liver Cirrhosis - Update and Current Challenges

IntechOpen

£101.00 19 Sep 2026
US Targeted Therapy Liver Cancer Drug Outlook 2023-2028
96% match

US Targeted Therapy Liver Cancer Drug Outlook 2023-2028

£490.00 07 Nov 2026
The 2023-2028 Outlook for Liver Health Supplements in the United States
96% match

The 2023-2028 Outlook for Liver Health Supplements in the United States

£520.00 03 Sep 2026
Chronic Liver Disease: From Molecular Biology to Therapy (Hepatology Research and Clinical Developments)
96% match

Chronic Liver Disease: From Molecular Biology to Therapy (Hepatology Research and Clinical Developments)

£252.99 27 Aug 2026
Pharmacotherapy for Liver Cirrhosis and Its Complications
96% match

Pharmacotherapy for Liver Cirrhosis and Its Complications

Springer

£80.65 18 Sep 2026
Hepatitis B Diagnostic Test Outlook 2023-2028 - US Study
96% match

Hepatitis B Diagnostic Test Outlook 2023-2028 - US Study

£490.00 05 Nov 2026
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
96% match

The 2016-2021 Outlook for Liver Cancer Drugs in Japan

£595.00 27 Aug 2026
The 2027-2032 World Outlook for NASH (Non-Alcoholic Steatohepatitis) Biomarkers
96% match

The 2027-2032 World Outlook for NASH (Non-Alcoholic Steatohepatitis) Biomarkers

£890.00 31 Aug 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China
96% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China

£495.00 06 Nov 2026
World Outlook for Liver Organs-on-Chips 2025-2030 Report
96% match

World Outlook for Liver Organs-on-Chips 2025-2030 Report

Price unavailable